Olopatadine Hydrochloride

CHEMBL1719 Phase 4 Aprobado Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

373.9 g/mol

LogP

—

Phase

4

A hydrochloride salt form of olopatadine with the same therapeutic properties. An antihistamine and mast cell stabilizer treating eye allergies, nasal allergies, and atopic dermatitis.

Peso molecular

373,9000 g/mol

TPSA

49,80 Å²

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Estructura 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

CN(C)CC/C=C1/c2ccccc2COc2ccc(CC(=O)O)cc21.Cl

InChI

InChI=1S/C21H23NO3.ClH/c1-22(2)11-5-8-18-17-7-4-3-6-16(17)14-25-20-10-9-15(12-19(18)20)13-21(23)24;/h3-4,6-10,12H,5,11,13-14H2,1-2H3,(H,23,24);1H/b18-8-;

Molecular Formula

C21H24ClNO3

HBD / HBA

2 / 4

Enlaces Rotables

5

Átomos Pesados

26

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Preguntas frecuentes

A hydrochloride salt form of olopatadine with the same therapeutic properties. An antihistamine and mast cell stabilizer treating eye allergies, nasal allergies, and atopic dermatitis.

Yes, Olopatadine Hydrochloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1719. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 5282402. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

¿Busca información accesible para el paciente?

Olopatadine Hydrochloride en PillFYI

Estructura

Datos Rápidos

Fórmula: C21H24ClNO3
Sinónimos: 23

Enlaces externos

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Aviso médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.